...
首页> 外文期刊>Stem Cell Research & Therapy >Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures
【24h】

Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures

机译:间充质干细胞的全身给药联合甲状旁腺激素治疗可协同再生多发性肋骨骨折

获取原文

摘要

Background A devastating condition that leads to trauma-related morbidity, multiple rib fractures, remain a serious unmet clinical need. Systemic administration of mesenchymal stem cells (MSCs) has been shown to regenerate various tissues. We hypothesized that parathyroid hormone (PTH) therapy would enhance MSC homing and differentiation, ultimately leading to bone formation that would bridge rib fractures. Methods The combination of human MSCs (hMSCs)?and a clinically relevant PTH dose was studied using immunosuppressed rats. Segmental defects were created in animals’ fifth and sixth ribs. The rats were divided into four groups: a negative control group, in which animals received vehicle alone; the PTH-only group, in which animals received daily subcutaneous injections of 4?μg/kg teriparatide, a pharmaceutical derivative of PTH; the hMSC-only group, in which each animal received five injections of 2?×?106 hMSCs; and the hMSC?+?PTH group, in which animals received both treatments. Longitudinal in vivo monitoring of bone formation was performed biweekly using micro-computed tomography (μCT), followed by histological analysis. Results Fluorescently-dyed hMSCs were counted using confocal microscopy imaging of histological samples harvested 8?weeks after surgery. PTH significantly augmented the number of hMSCs that homed to the fracture site. Immunofluorescence of osteogenic markers, osteocalcin and bone sialoprotein, showed that PTH induced cell differentiation in both exogenously administered cells and resident cells. μCT scans revealed a significant increase in bone volume only in the hMSC?+?PTH group, beginning by the 4th week after surgery. Eight weeks after surgery, 35% of ribs in the hMSC?+?PTH group had complete bone bridging, whereas there was complete bridging in only 6.25% of ribs (one rib) in the PTH-only group and in none of the ribs in the other groups. Based on the μCT scans, biomechanical analysis using the micro-finite element method demonstrated that the healed ribs were stiffer than intact ribs in torsion, compression, and bending simulations, as expected when examining bone callus composed of woven bone. Conclusions Administration of both hMSCs and PTH worked synergistically in rib fracture healing, suggesting this approach may pave the way to treat multiple rib fractures as well as additional fractures in various anatomical sites.
机译:背景技术导致创伤相关疾病的灾难性疾病,多处肋骨骨折仍是严重的临床需求。间充质干细胞(MSCs)的全身给药已显示可再生各种组织。我们假设甲状旁腺激素(PTH)治疗会增强MSC的归巢和分化,最终导致桥接肋骨骨折的骨形成。方法采用免疫抑制大鼠研究人间充质干细胞(hMSCs)与临床相关PTH剂量的组合。在动物的第五和第六肋骨上出现了节段性缺陷。将大鼠分为四组:阴性对照组,其中动物单独接受赋形剂;对照组,动物单独接受赋形剂。仅PTH组,动物每天皮下注射PTH的药物衍生物4?μg/ kg特立帕肽。仅hMSC组,其中每只动物接受5次2××10 10 6 supshMSC的注射。和hMSCα+βPTH组,其中动物接受两种治疗。每两周使用微计算机断层扫描(μCT)对骨骼形成进行纵向体内监测,然后进行组织学分析。结果共聚焦显微镜对术后8周收集的组织学标本进行荧光染色hMSCs计数。 PTH显着增加了驻留在骨折部位的hMSC的数量。成骨标记物,骨钙素和骨唾液蛋白的免疫荧光显示,PTH诱导了外源给药细胞和驻留细胞的细胞分化。 μCT扫描显示,仅在hMSC?+?PTH组中,从手术后第4周开始,骨体积显着增加。术后八周,hMSCα+βPTH组中35%的肋骨已完全桥接,而仅PTH组中仅6.25%的肋骨(一个肋骨)完全桥接,而在PTH组中没有肋骨。其他组。基于μCT扫描,使用微有限元方法进行的生物力学分析表明,在检查扭曲,压缩和弯曲模拟时,愈合的肋骨比完整的肋骨要硬,正如检查由编织骨组成的骨call时所期望的那样。结论hMSCs和PTH的管理在肋骨骨折愈合中具有协同作用,这表明该方法可能为治疗多处肋骨骨折以及其他解剖部位的其他骨折铺平道路。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号